Novo Nordisk to invest heavily in Danish manufacturing plant
This article was originally published in Scrip
Executive Summary
Novo Nordisk is investing almost DKK1 billion (€134 million) in a new factory in Kalundborg, Denmark, for the production of biopharmaceuticals.